Physician profile
Mujeeb A Sheikh
NPI 1104080308
$777.16
in general payments reported to CMS, 2019-2025
15 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.42 · 2021: $167 · 2022: $171 · 2023: $61.45 · 2024: $195 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $377.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $160.69 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $136.25 | 2021-2025 | |
| Abiomed | $115.53 | 2021-2025 | |
| Inari Medical, INC. | $107.47 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $60.49 | 2021-2025 | Eliquis |
| Boston Scientific Corporation | $35.35 | 2025 | Watchman Flx |
| Pfizer INC. | $25.57 | 2019-2024 | |
| Abbott Laboratories | $23.96 | 2022 | |
| Ge Healthcare | $18.98 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $18.30 | 2024 | |
| Philips North America LLC | $17.72 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.54 | 2024 | Lifevest |
| Chiesi USA, INC. | $14.48 | 2024 | Cleviprex, Kengreal |
| Janssen Pharmaceuticals, INC | $13.61 | 2023 | Xarelto |
| Cook Medical LLC | $13.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mujeeb Sheikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.